lonoctocog alfa 1 UNT Injection
- RxCUI
- 1796379
- RxNorm name
- lonoctocog alfa 1 UNT Injection
- Display name
- lonoctocog alfa 1 UNT Injection
- Full name
- lonoctocog alfa 1 UNT Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:58
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125591 | Afstyla | Antihemophilic Factor (Recombinant), Single Chain | 351(a) | Rx | 2026-10-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AFSTYLA Antihemophilic Factor (Recombinant), Single Chain | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | CSL Behring Lengnau AG | 51f19873-a63f-4229-9477-5da4ecf31cde | 2023-06-23 | Warnings, Adverse reactions | 1796379 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 51f19873-a63f-4229-9477-5da4ecf31cde | antihemophilic factor (recombinant) single chain 1 UNT Injection [PSN] · lonoctocog alfa 1 UNT Injection [SCD] · antihemophilic factor (recombinant) single chain 1 UNT Injection [SY] | 3 | 13 | These highlights do not include all the information needed to use AFSTYLA safely and effectively. See full prescribing information for AFSTYLA. AFSTYLA ® [Antihemophilic Factor (Recombinant), Single Chain] Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2016 | 20230623 |